SpliceBio
About SpliceBio
SpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to develop the next generation of gene therapies. The company focuses on innovative solutions for genetic disorders, particularly in the field of ophthalmology.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
🚨 Record-breaking news! Barcelona’s @SpliceBioHQ raises €118M, the largest Series A in Spain’s biotech history! Catalonia continues to lead in #genetherapy and biotech innovation 👏 More 👉 https://t.co/LX2zZgwMNi #Biotech #Barcelona #SpliceBio #LifeSciences #Catalonia
SpliceBio, a Barcelona, Spain-based clinical-stage genetic medicines company, raised $135M in Series B funding https://t.co/SpJwQH5NpM
Catch up on the latest news highlights on RegMedNet, including: 🗞️Capsida Biotherapeutics' IND approval 🗞️Capstan Therapeutics' in vivo CAR-T therapy for autoimmune disorders 🗞️SpliceBio's successful Series B funding round Get all the details >>> https://t.co/lANvoU1UZD https://t.co/1B0HsWkqkd
Similar Startups
Spark Biomedical
88% matchSpark Biomedical is focused on developing innovative solutions for pain management and addiction tre...
CureGene Pharma
87% matchCureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...
inductive_bio
87% matchA platform that accelerates the discovery of life-changing therapeutics using state-of-the-art AI mo...
AusperBio
87% matchA clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.